Dr. William Binder, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $150.1M | 43 | 100.0% |
| Food and Beverage | $2,252 | 21 | 0.0% |
| Travel and Lodging | $173.15 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $96.3M | 41 | $0 (2022) |
| ABBVIE INC. | $53.8M | 11 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $1,632 | 12 | $0 (2024) |
| Horizon Therapeutics plc | $17.24 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7.4M | 5 | ABBVIE INC. ($7.4M) |
| 2023 | $29.4M | 7 | AbbVie Inc. ($29.4M) |
| 2022 | $28.3M | 7 | ABBVIE INC. ($17.0M) |
| 2021 | $21.9M | 11 | Allergan, Inc. ($21.9M) |
| 2020 | $19.0M | 6 | Allergan, Inc. ($19.0M) |
| 2019 | $20.7M | 8 | Allergan Inc. ($20.7M) |
| 2018 | $16.7M | 11 | Allergan Inc. ($16.7M) |
| 2017 | $6.6M | 10 | Allergan Inc. ($6.6M) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $92.64 | General |
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $2,225,183.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/27/2024 | ABBVIE INC. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $1,929,365.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/28/2024 | ABBVIE INC. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $884,805.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/28/2024 | ABBVIE INC. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $2,381,550.58 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/21/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $137.39 | General |
| Category: Dermatology | ||||||
| 11/30/2023 | AbbVie Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $10,069,861.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/29/2023 | AbbVie Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $7,385,187.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/09/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $129.43 | General |
| Category: Dermatology | ||||||
| 05/30/2023 | AbbVie Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $4,208,250.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/21/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $147.05 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/28/2023 | AbbVie Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $7,770,644.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/15/2022 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $187.78 | General |
| Category: Dermatology | ||||||
| 11/29/2022 | ABBVIE INC. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $10,547,516.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2022 | ABBVIE INC. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $6,437,629.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2022 | Allergan, Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $1,641,302.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/28/2022 | Allergan, Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $9,682,565.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/31/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 03/03/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: TEPEZZA | ||||||
| 12/15/2021 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $107.46 | General |
| Category: Dermatology | ||||||
| 11/22/2021 | Allergan, Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $8,521,660.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/01/2021 | Allergan, Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $5,526,590.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/24/2021 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Dermatology | ||||||
| 05/28/2021 | Allergan, Inc. | BOTOX (Biological) | Royalty or License | Cash or cash equivalent | $2,783,617.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/19/2021 | Allergan, Inc. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $173.15 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. William Binder, M.D
Dr. William Binder, M.D is a Plastic Surgery Within the Head and Neck healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205980448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Binder, M.D has received a total of $150.1M in payments from pharmaceutical and medical device companies, with $7.4M received in 2024. These payments were reported across 65 transactions from 4 companies. The most common payment nature is "Royalty or License" ($150.1M).
Practice Information
- Specialty Plastic Surgery Within the Head and Neck
- Location Beverly Hills, CA
- Active Since 01/23/2007
- Last Updated 07/08/2007
- Taxonomy Code 2082S0099X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205980448
Products in Payments
- BOTOX (Biological) $110.4M
- BOTOX COSMETIC (Biological) $39.7M
- Xeomin (Biological) $862.06
- XEOMIN (Biological) $527.73
- TEPEZZA (Drug) $17.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Plastic Surgery Within the Head and Neck Doctors in Beverly Hills
Dr. Farhad Ardeshirpour-Zartoshti, M.d, M.D
Plastic Surgery Within the Head and Neck — Payments: $56,441
Fadi Chahin, Md, MD
Plastic Surgery Within the Head and Neck — Payments: $5,986
Dr. Donald Yoo, M.d, M.D
Plastic Surgery Within the Head and Neck — Payments: $1,443
Dr. Kriya Gishen, Md, MD
Plastic Surgery Within the Head and Neck — Payments: $487.97
Dr. Harrison Lee, Md, Dmd, Facs, MD, DMD, FACS
Plastic Surgery Within the Head and Neck — Payments: $33.38
Justin Rome, M.d, M.D
Plastic Surgery Within the Head and Neck — Payments: $28.63